Medicine
Penicillin v 250 mg tablet
Penicillin v 250 mg tablet is a generic prescription medicine for oral use, made by 13 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Penicillin v
- Brand
- Sold under the generic name
- Strength
- 250 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 30 tablets and 60 more
- Manufacturers
- Aurobindo PharmaIndiaNuCare Pharmaceuticals,IncPD-Rx PharmaceuticalsChartwell RXHikma PharmaceuticalsRising HealthTeva Pharmaceuticals13 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01CE02 Penicillin v
- HS code (indicative)
- 3004.10Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 September 1990
- Identifiers
- RxCUI 834061, 834040, 834046 +1DailyMed set ID 281f9c32-e28a-46ae-9e4e-c2143aaa6c6b, b0744674-ddf7-4022-be2f-2a22bef0d379, 7ee64c92-7d60-d230-e053-2a91aa0a796e +27NDC 43063-622, 62135-098, 68071-4697 +27Application ANDA065435, ANDA060711, ANDA090549
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 13 labelers. The register lists 63 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 65862-175-01 | Aurobindo PharmaIndia | 29 April 2008 |
| 1000 tablet, film coated in 1 bottle | 65862-175-99 | Aurobindo PharmaIndia | 29 April 2008 |
| 100 tablet in 1 bottle | 62135-098-01 | Chartwell RX | 23 July 2026 |
| 30 tablet in 1 bottle | 62135-098-30 | Chartwell RX | 16 July 2026 |
| 100 tablet, film coated in 1 bottle | 0143-9837-01 | Hikma Pharmaceuticals | 11 October 2013 |
| 1000 tablet, film coated in 1 bottle | 0143-9837-10 | Hikma Pharmaceuticals | 11 October 2013 |
| 100 tablet, film coated in 1 bottle | 57237-040-01 | Rising Health | 29 April 2008 |
| 1000 tablet, film coated in 1 bottle | 57237-040-99 | Rising Health | 29 April 2008 |
| 100 tablet in 1 bottle | 0093-1172-01 | Teva Pharmaceuticals | 30 September 1990 |
| 1000 tablet in 1 bottle | 0093-1172-10 | Teva Pharmaceuticals | 30 September 1990 |
| 6 tablet in 1 bottle | 68071-2244-6 | NuCare Pharmaceuticals,Inc | 24 August 2020 |
| 20 tablet, film coated in 1 bottle | 68071-3176-2 | NuCare Pharmaceuticals | 17 March 2017 |
| 30 tablet, film coated in 1 bottle | 68071-3176-3 | NuCare Pharmaceuticals | 17 March 2017 |
| 40 tablet, film coated in 1 bottle | 68071-3176-4 | NuCare Pharmaceuticals | 17 March 2017 |
| 6 tablet, film coated in 1 bottle | 68071-3176-6 | NuCare Pharmaceuticals | 17 March 2017 |
| 28 tablet, film coated in 1 bottle | 68071-3176-8 | NuCare Pharmaceuticals | 17 March 2017 |
| 40 tablet, film coated in 1 bottle | 68071-3401-4 | NuCare Pharmaceuticals,Inc | 16 May 2023 |
| 6 tablet, film coated in 1 bottle | 68071-3427-6 | NuCare Pharmaceuticals,Inc | 6 June 2023 |
| 40 tablet, film coated in 1 bottle | 68071-3562-4 | NuCare Pharmaceuticals,Inc | 24 January 2024 |
| 3 tablet, film coated in 1 bottle | 68071-4298-3 | NuCare Pharmaceuticals,Inc | 6 December 2024 |
| 4 tablet, film coated in 1 bottle | 68071-4298-4 | NuCare Pharmaceuticals,Inc | 23 February 2018 |
| 6 tablet, film coated in 1 bottle | 68071-4298-6 | NuCare Pharmaceuticals,Inc | 23 February 2018 |
| 8 tablet, film coated in 1 bottle | 68071-4298-8 | NuCare Pharmaceuticals,Inc | 23 February 2018 |
| 9 tablet, film coated in 1 bottle | 68071-4298-9 | NuCare Pharmaceuticals,Inc | 23 February 2018 |
| 40 tablet, film coated in 1 bottle | 68071-4697-4 | NuCare Pharmaceuticals,Inc | 7 January 2019 |
| 28 tablet, film coated in 1 bottle | 68071-4697-8 | NuCare Pharmaceuticals,Inc | 7 January 2019 |
| 6 tablet, film coated in 1 bottle | 68071-4753-6 | NuCare Pharmaceuticals,Inc | 6 February 2019 |
| 8 tablet, film coated in 1 bottle | 68071-4753-8 | NuCare Pharmaceuticals,Inc | 6 February 2019 |
| 40 tablet, film coated in 1 bottle, plastic | 43063-622-40 | PD-Rx Pharmaceuticals | 26 October 2015 |
| 6 tablet, film coated in 1 bottle, plastic | 43063-704-06 | PD-Rx Pharmaceuticals | 2 November 2016 |
| 20 tablet, film coated in 1 bottle, plastic | 43063-704-20 | PD-Rx Pharmaceuticals | 19 September 2016 |
| 28 tablet, film coated in 1 bottle, plastic | 43063-704-28 | PD-Rx Pharmaceuticals | 22 August 2016 |
| 40 tablet, film coated in 1 bottle, plastic | 43063-704-40 | PD-Rx Pharmaceuticals | 15 December 2016 |
| 6 tablet, film coated in 1 bottle, plastic | 72789-146-06 | PD-Rx Pharmaceuticals | 30 December 2020 |
| 20 tablet, film coated in 1 bottle, plastic | 72789-146-20 | PD-Rx Pharmaceuticals | 30 December 2020 |
| 28 tablet, film coated in 1 bottle, plastic | 72789-146-28 | PD-Rx Pharmaceuticals | 15 March 2021 |
| 100 tablet, film coated in 1 bottle, plastic | 72789-223-01 | PD-Rx Pharmaceuticals | 11 February 2022 |
| 20 tablet, film coated in 1 bottle, plastic | 72789-245-20 | PD-Rx Pharmaceuticals | 18 April 2025 |
| 28 tablet, film coated in 1 bottle, plastic | 72789-245-28 | PD-Rx Pharmaceuticals | 11 October 2023 |
| 40 tablet, film coated in 1 bottle, plastic | 72789-245-40 | PD-Rx Pharmaceuticals | 12 April 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | Approved | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Penicillin v
Clinical summary
Penicillin v is a penicillin-class antibacterial indicated in the treatment of mild to moderately severe infections due to penicillin G-sensitive microorganisms, among other approved uses. It is available as tablets and powder for oral solution. MedsAcross supplies Penicillin v for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Penicillin vFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Penicillin V Potassium prescribing information (Chartwell RX) · U.S. National Library of Medicine, DailyMed
Need Penicillin v 250 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.